Is Apollo Hospitals overvalued or undervalued?

As of 24 October 2025, Apollo Hospitals' valuation grade has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company is currently assessed as undervalued. Key ratios include a PE Ratio of 71.66, an EV to EBITDA of 36.84, and a ROE of 17.61%.
In comparison to its peers, Apollo Hospitals stands out with a PEG Ratio of 1.38, while Max Healthcare and Fortis Health are significantly more expensive with PE Ratios of 95.69 and 84.7, respectively. Despite a slight decline in stock price recently, Apollo Hospitals has outperformed the Sensex over the past year, with a return of 12.42% compared to the Sensex's 5.18%.